Patent · US Active

Substituted 3-(5-membered unsaturated heterocyclyl-1, 3-dihydro-indol-2-one's and derivatives thereof as kinase inhibitors

US9758509B2 · kind B2 · utility

0Cited by
23References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 6, 2017
Grant dateSep 12, 2017
Priority date
Expiry dateMar 6, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F7/1804
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.